Clinical Trials Logo

Clinical Trial Summary

Purpose: To establish of the national Inherited Retinal Dystrophy Registry (IRDR) in Iran.

Methods: This study is a community-based participatory research that is approved by the Ministry of Health and Medical Education of Iran in 2016. To provide the minimum data set (MDS), several focus group meetings will be held with participation of the faculty members of the Ophthalmic Research Center affiliated to Shahid Beheshti University of Medical Sciences (SBMU). Final MDS will be presented to the software engineering team to develop a web-based software. In the pilot phase, software will be set up in two referral centers including Labbafinejad Medical Center (Tehran) and Alzahra Eye Hospital (Zahedan) to discover the possible drawbacks. Final diagnosis will be made based on both clinical manifestations as well as genetic findings.The steering committee meetings are planned to be held each year with the presence of delegates of all centers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Inherited Retinal Dystrophy Primarily Involving Retinal Pigment Epithelium
  • Inherited Retinal Dystrophy Primarily Involving Sensory Retina
  • Retinal Dystrophies

NCT number NCT04131400
Study type Observational [Patient Registry]
Source Shahid Beheshti University of Medical Sciences
Contact
Status Recruiting
Phase
Start date January 1, 2017
Completion date June 1, 2021

See also
  Status Clinical Trial Phase
Terminated NCT03561922 - Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS N/A
Recruiting NCT05626920 - Disulfiram for Treatment of Retinal Degeneration Phase 1/Phase 2
Completed NCT03613948 - Study on the Effects of Mutations Under Inherited Retinal Disease in Korean